FIUME, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 2.383
AS - Asia 1.596
EU - Europa 1.461
AF - Africa 134
SA - Sud America 73
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 6
Totale 5.718
Nazione #
US - Stati Uniti d'America 2.352
CN - Cina 483
VN - Vietnam 403
SG - Singapore 395
GB - Regno Unito 381
IT - Italia 247
DE - Germania 148
SE - Svezia 144
UA - Ucraina 125
IN - India 89
FR - Francia 85
HK - Hong Kong 84
RU - Federazione Russa 72
CH - Svizzera 57
TG - Togo 56
BR - Brasile 55
IE - Irlanda 46
JP - Giappone 33
ZA - Sudafrica 30
FI - Finlandia 28
EE - Estonia 25
NL - Olanda 20
BG - Bulgaria 19
BD - Bangladesh 18
BE - Belgio 18
KR - Corea 18
CA - Canada 16
CI - Costa d'Avorio 16
PH - Filippine 14
SC - Seychelles 14
NG - Nigeria 11
IQ - Iraq 10
HR - Croazia 9
TH - Thailandia 9
AR - Argentina 8
PL - Polonia 8
GR - Grecia 6
JO - Giordania 6
SA - Arabia Saudita 6
AT - Austria 5
ID - Indonesia 5
MX - Messico 5
AU - Australia 4
ES - Italia 4
JM - Giamaica 4
RO - Romania 4
TW - Taiwan 4
EC - Ecuador 3
IL - Israele 3
LT - Lituania 3
TR - Turchia 3
CO - Colombia 2
ET - Etiopia 2
IR - Iran 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BT - Bhutan 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
HN - Honduras 1
KE - Kenya 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
Totale 5.654
Città #
Southend 317
Ashburn 282
Singapore 264
Fairfield 240
Chandler 208
Woodbridge 141
Wilmington 128
Houston 111
Seattle 109
Ann Arbor 106
Santa Clara 97
San Jose 93
Jacksonville 81
Hong Kong 79
Ho Chi Minh City 78
Cambridge 68
Princeton 68
Beijing 64
Bern 56
Lomé 56
Bologna 54
Hanoi 50
Hefei 50
Dublin 46
New York 46
Boardman 41
Council Bluffs 40
Dong Ket 33
Padova 31
Westminster 30
Tokyo 29
Los Angeles 27
Lauterbourg 26
Helsinki 22
Nanjing 21
Berlin 20
Shenyang 19
Sofia 19
Brussels 18
Turin 18
Abidjan 16
Buffalo 16
Jinan 16
Dallas 15
Saint Petersburg 15
Nanchang 14
Hangzhou 13
Mülheim 13
Haiphong 12
Mahé 12
Seoul 12
Cesenatico 11
Changsha 11
Da Nang 11
Abeokuta 10
Guangzhou 10
Milan 10
San Diego 10
Shanghai 10
Falls Church 9
Zhengzhou 9
Falkenstein 8
Jiaxing 8
Redondo Beach 8
Redwood City 8
São Paulo 8
Tianjin 8
Tân Tiến 8
Baghdad 7
Hebei 7
Wuhan 7
Bengaluru 6
Chicago 6
Frankfurt am Main 6
Haikou 6
London 6
Phoenix 6
Redmond 6
The Dalles 6
Verona 6
Yubileyny 6
Amman 5
Can Tho 5
Dearborn 5
Düsseldorf 5
Montreal 5
Nuremberg 5
Olalla 5
Sant'agata De' Goti 5
Turku 5
Warsaw 5
Bangkok 4
Brooklyn 4
Cape Town 4
Castel Maggiore 4
Chennai 4
Des Moines 4
Kunming 4
Medford 4
Pianoro 4
Totale 3.764
Nome #
A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. 245
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 238
Uso di coniugati della doxorubicina con albumina lattosaminata 229
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 227
Liver targeted doxorubicin: effects on rat regenerating hepatocytes. 219
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 218
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 213
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 208
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 204
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 203
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin 202
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 199
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 197
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 196
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 193
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 186
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 186
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 183
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 173
Procedura per la preparazione di coniugati della doxorubicina con l’albumina umana lattosaminata 172
Albumin-drug conjugates in the treatment of hepatic disorders. 172
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 170
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. 168
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis 155
Process for the preparation of doxorubicin conjugates with lactosaminated human albumin 154
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. 146
Use of conjugates of doxorubicin with lactosaminated albumin. 144
Lactosaminated human albumin: a hepatotropic carrier of drugs. 135
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 123
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 111
null 78
null 71
Totale 5.718
Categoria #
all - tutte 15.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022557 0 14 51 55 52 29 29 36 23 45 128 95
2022/2023753 81 143 33 89 52 58 14 33 108 10 38 94
2023/2024204 12 31 22 23 6 68 7 11 2 11 3 8
2024/2025606 30 68 47 69 131 42 43 28 7 33 10 98
2025/20261.490 124 142 125 133 160 97 101 26 355 139 39 49
2026/202774 32 42 0 0 0 0 0 0 0 0 0 0
Totale 5.718